UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 13, 2003
PACIFICHEALTH LABORATORIES, INC.
--------------------------------------------------
(Exact name of registrant as specified in charter)
Delaware 000-23495 22-3367588
--------------- ----------- -------------
(State of other (Commission (IRS Employer
jurisdiction of File Number) Identification
incorporation) Number)
1480 Route 9 North - Suite 204, Woodbridge, New Jersey 15220
------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (732) 636-6141
--------------
N/A
--------------------------------------------------------------
(Former name or former address, if changed since last report.)
Item 7. Financial Statements and Exhibits.
(a) Not applicable.
(b) Not applicable.
(c) Exhibits
Exhibit No. Description
----------- ------------
99.1 Press release dated May 7, 2003.
Item 9. Regulation FD Disclosure (Information furnished under Item 12 - Results
of Operations and Financial Condition).
On May 13, 2003, PacificHealth Laboratories, Inc. issued a press
release announcing its financial results for the fiscal quarter ended March 31,
2003. A copy of the press release is attached hereto as Exhibit 99.1 and
incorporated herein by reference. The information included in the attached
exhibit and contained in Item 9 of this Current Report is being furnished
pursuant to "Item 12. Results of Operations and Financial Condition" of Form 8-K
in accordance with SEC Release Nos. 33-8216 and 34-47583. This information shall
not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act
of 1934, as amended (the "Exchange Act"), or incorporated by reference in any
filing under the Securities Act of 1933, as amended, or the Exchange Act, except
as shall be expressly incorporated by specific reference in such a filing.
SIGNATURE
---------
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
PACIFICHEALTH LABORATORIES, INC.
Dated: May 13, 2003 By: Stephen P. Kuchen
------------------------------
Stephen P. Kuchen
Chief Financial Officer
Exhibit Index
-------------
Exhibit No. Description
----------- -----------
99.1 Press release dated May 13, 2003